NCT04545229

Brief Summary

A randomized controlled trial to evaluate the efficacy of the VR-based Pain Alleviation Tool (VR-PAT) in reducing opioid pain medication use during adult burn dressing changes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable pain

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 24, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 24, 2019

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 1, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 10, 2020

Completed
Last Updated

April 30, 2024

Status Verified

April 1, 2024

Enrollment Period

10 months

First QC Date

September 1, 2020

Last Update Submit

April 29, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patient self-reported pain

    Patient self-reported pain using the 100mm Visual Analog Scale (VAS), 0 (min)-100(max), higher score for worse outcome.

    During burn dressing changes

Secondary Outcomes (1)

  • Opioid medication utilization, morphine equivalent dose per day during inpatient hospital stay.

    Each day during inpatient hospital stays up to 7 days.

Other Outcomes (2)

  • Patient VR experience

    Subjective experience during burn dressing change, on average lasting 15-45 minutes.

  • Nurse reported feasibility of VR in clinical burn wound care

    Subjective observation of patient's utilization of VR during burn dressing change, on average lasting 15-45 minutes.

Study Arms (3)

Active VR-PAT

EXPERIMENTAL

Active VR-based Pain Alleviation Tool (VR-PAT) group played smart phone VR-PAT during the burn dressing changes.

Other: VR-based Pain Alleviation Tool (VR-PAT)

Passive VR-PAT

EXPERIMENTAL

Passive VR-based Pain Alleviation Tool (VR-PAT) group watched smart phone VR-PAT games without interaction during the burn dressing changes.

Other: VR-based Pain Alleviation Tool (VR-PAT)

Standard Care Control

NO INTERVENTION

Standard care control group used regular distraction such as background music or no distraction.

Interventions

Four smart phone based virtual reality games developed by the Research Information Solutions and Innovation (RISI) at the Nationwide Children's Hospital.

Active VR-PATPassive VR-PAT

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult burn patient age 18-70
  • First admission for acute burn requiring dressing change
  • First admission for burn injury
  • Using Opioids for dressing changes
  • Burn is ≤ 4 days post burn

You may not qualify if:

  • Severe burn(s) on the face/head preventing utilization of VR
  • Cognitive/motor impairment preventing valid administration of study measures
  • Unable to communicate in English
  • Prisoners and patients who were pregnant
  • Patients admitted to the ICU

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nationwide Children's Hospital

Columbus, Ohio, 43205, United States

Location

Related Publications (1)

  • Armstrong M, Coffey R, Luna J, Xiang H. Pilot randomized clinical trial of virtual reality pain management during adult burn dressing changes: Lessons learned. PLOS Digit Health. 2023 Sep 25;2(9):e0000231. doi: 10.1371/journal.pdig.0000231. eCollection 2023 Sep.

MeSH Terms

Conditions

PainBurns

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsWounds and Injuries

Study Officials

  • Henry Xiang, MD, MPH, PhD

    The Ohio State University/Nationwide Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
In this pilot study, no masking was implemented.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Three-group RCT
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Center Director

Study Record Dates

First Submitted

September 1, 2020

First Posted

September 10, 2020

Study Start

February 1, 2019

Primary Completion

November 24, 2019

Study Completion

November 24, 2019

Last Updated

April 30, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

We are not allowed to share patient medical records data.

Locations